ESC Congress 2008 article schedule

Reminders for Mike

 * Email Dr. Brunner a reminder about the TIME-CHF slides. Done. Waiting on response.
 * Email Dr. Terje Pedersen about SEAS slides.

Sunday, August 31
Trial of Intensified (BNP-guided) versus standard (symptom-guided) Medical therapy in Elderly patients with Congestive Heart Failure TIME-CHF.
 * Author: Katherine
 * Slides: Coming. Mike, you may want to email a reminder to Dr. Brunner.

The BEAUTIFUL study: efficacy of ivabradine in reduction of cardiovascular events among atients with stable coronary artery disease and left ventricular dysfunction.
 * Author: Alex Done
 * Slides: No

Effects of n-3 PUFA in patients with symptomatic chronic heart failure: the GISSI-HF results.
 * Author: Leah Done
 * Slides: No

Effects of statins in patients with symptomatic chronic heart failure: the GISSI-HF results.
 * Author: Vijay Done
 * Slides: No

The TRANSCEND Study: a randomized placebo-controlled clinical trial evaluating the effects of telmiartan in high risk individuals without heart failure.
 * Author: Scott, done
 * Slides: No

Monday, September 1
Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery. Results from a randomized placebo controlled trial: DECREASE III.
 * Author: Katherine
 * Slides: No

The SYNergy between Percutaneous Coronary Intervention and Cardiac Surgery (SYNTAX) Study.
 * Author: Alex
 * Slides: No

Coronary Artery Revascularisation and Diabetes. The CARDia trial.
 * Author: Leah
 * Slides: No

LEADERS- Limus Eluted from A Durable versus Erodable stent coating (Randomized Comparison of a biolimus-A9 eluting stent with a sirolimus-eluting stent for percutaneous coronary intervention).
 * Author: Scott
 * Slides: Yes

Tuesday, September 2
Myocardial Regeneration b Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infartion (REGENT) Randomized Multicenter Trial.
 * Author: Katherine
 * Slides: No

The effects of the direct Lipoprotein-associated phospholipase A2 Inhibitor Darapladib on human coronary atherosclerotic plaque.
 * Author:Vijay
 * Slides: No

Safety of the factor Xa inhibitor, Apixaban, in combination with antiplatelet therapy after acute coronary syndrome: Results of the APPRAISE-I dose guiding trial.
 * Author: Alex
 * Slides: Yes

Main Results of the Tailoring Treatment with Tirofiban in patients showing Resistance to aspirin or Resistance to clopidogrel study (3T/2R).
 * Author: Leah
 * Slides: Yes

A Multicenter, Double blind, Randomized, Placebo Controlled Study to Measure the Effect of FX06 on Ischemia Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (The F.I.R.E. Trial).
 * Author: Scott
 * Slides: Yes

Simvastatin plus ezetimidbe in aortic stenosis - The SEAS study.
 * Author: Vijay
 * Slides: Mike, you need to email Dr. Terje Pedersen about his slide set.